Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Authors
Keywords
-
Journal
Cancer Cell International
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-26
DOI
10.1186/s12935-022-02831-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncogenic gain of function due to p53 amyloids occurs through aberrant alteration of cell cycle and proliferation
- (2022) Ambuja Navalkar et al. JOURNAL OF CELL SCIENCE
- Context dependent role of p53 during the interaction of hepatocellular carcinoma and endothelial cells
- (2022) Shaikh Maryam Ghufran et al. MICROVASCULAR RESEARCH
- Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
- (2022) Katarzyna A. Roszkowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p53 amyloid aggregation in cancer: function, mechanism, and therapy
- (2022) Jingzhi Li et al. Experimental Hematology & Oncology
- Cancer Stemness: p53 at the Wheel
- (2021) Dishari Ghatak et al. Frontiers in Oncology
- Reactivation of the Guardian of the Genome P53: A Promising Strategy for Treatment of Cancer
- (2021) Ahmed F. Abdel-Magid ACS Medicinal Chemistry Letters
- Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
- (2021) Eduardo Alvarado-Ortiz et al. Frontiers in Cell and Developmental Biology
- Direct evidence of cellular transformation by prion-like p53 amyloid infection
- (2021) Ambuja Navalkar et al. JOURNAL OF CELL SCIENCE
- MicroRNA-324-5p–CUEDC2 Axis Mediates Gain-of-Function Mutant p53-Driven Cancer Stemness
- (2021) Dishari Ghatak et al. MOLECULAR CANCER RESEARCH
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
- (2021) L. Palanikumar et al. Nature Communications
- Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer
- (2021) Joe Christianson et al. Frontiers in Oncology
- Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia
- (2021) Anuradha Kirtonia et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Structural and Functional Insights into α-Synuclein Fibril Polymorphism
- (2021) Surabhi Mehra et al. Biomolecules
- Changes in gene-gene interactions associated with cancer onset and progression are largely independent of changes in gene expression
- (2021) Zainab Arshad et al. iScience
- The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma
- (2020) Xuejiao Chen et al. Biomolecules
- Cas9 activates the p53 pathway and selects for p53-inactivating mutations
- (2020) Oana M. Enache et al. NATURE GENETICS
- Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
- (2020) Simon Dujardin et al. NATURE MEDICINE
- Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis
- (2020) Shengnan Sun et al. Cell Death & Disease
- Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes
- (2020) Anne Ward et al. Acta Neuropathologica Communications
- P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease
- (2020) Kathleen M. Farmer et al. Acta Neuropathologica Communications
- Non-coding RNAs, guardians of the p53 galaxy
- (2020) Song Chen et al. SEMINARS IN CANCER BIOLOGY
- TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
- (2020) Jayakumar Vadakekolathu et al. Blood Advances
- Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
- (2020) Xiufang Xu et al. Molecular Cancer
- p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells
- (2019) Luciana P. Rangel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
- (2019) Max D. Wellenstein et al. NATURE
- Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairıng effect in human prostate cancer cell line PC-3
- (2019) Muhammet Burak Batır et al. MOLECULAR BIOLOGY REPORTS
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
- (2019) Hiroshi Handa et al. Cancers
- Biophysical characterization of p53 core domain aggregates
- (2019) Igor Lima et al. BIOCHEMICAL JOURNAL
- Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
- (2019) Yan Stein et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial Mesenchymal Transition in Tumor Metastasis
- (2018) Vivek Mittal Annual Review of Pathology-Mechanisms of Disease
- Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
- (2018) Matthias G.J. Baud et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers
- (2018) Hilla Solomon et al. ONCOGENE
- Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
- (2018) Tomer Cooks et al. Nature Communications
- Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases
- (2018) Yun Zhang et al. Nature Communications
- p53 activation: a checkpoint for precision genome editing?
- (2018) Anastasia Conti et al. Genome Medicine
- Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
- (2018) Amit Gupta et al. BIOMEDICINE & PHARMACOTHERAPY
- Awakening the “guardian of genome”: reactivation of mutant p53
- (2018) Akshay Binayke et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Base editing: precision chemistry on the genome and transcriptome of living cells
- (2018) Holly A. Rees et al. NATURE REVIEWS GENETICS
- Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide
- (2017) Asa Hatami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer
- (2017) Xiao Ling Li et al. Cell Reports
- Harnessing Fluorine–Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs
- (2016) Matthias R. Bauer et al. ACS Chemical Biology
- The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
- (2016) Andreas C. Joerger et al. Annual Review of Biochemistry
- Novel targets and interaction partners of mutant p53 Gain-Of-Function
- (2016) Lydia Aschauer et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma
- (2016) Chuan-chuan Zhou et al. HEPATOLOGY
- Reactivation of mutant p53 by capsaicin, the major constituent of peppers
- (2016) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
- (2016) Marco Cordani et al. Molecular Oncology
- Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction
- (2016) T Q Tran et al. ONCOGENE
- Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5
- (2016) Fotini Vogiatzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells
- (2016) Kathryn E. Yoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells
- (2016) Matthias R. Bauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?
- (2016) Danielly C.F. Costa et al. Cold Spring Harbor Perspectives in Biology
- Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
- (2016) Perry Tal et al. Oncotarget
- Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells
- (2016) Salman B. Hosain et al. Oncotarget
- The role of p53 in cancer drug resistance and targeted chemotherapy
- (2016) Karin Hientz et al. Oncotarget
- Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin
- (2016) Renu Wadhwa et al. Journal of Cancer
- TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
- (2016) Yuki Kawarada et al. Scientific Reports
- Novel therapeutic interventions for p53-altered tumors through manipulation of its family members, p63 and p73
- (2015) Avinashnarayan Venkatanarayan et al. CELL CYCLE
- PI3King the Lock
- (2015) David King et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb
- (2015) S. Agarwal et al. MOLECULAR CANCER RESEARCH
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding
- (2015) GuoZhen Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
- (2015) Min-Che Tung et al. Oncotarget
- Regulation of Mutant p53 Protein Expression
- (2015) Reshma Vijayakumaran et al. Frontiers in Oncology
- TDP-43 Inhibits NF-κB Activity by Blocking p65 Nuclear Translocation
- (2015) Jingyan Zhu et al. PLoS One
- LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
- (2015) Xiaoyan Li et al. Oncotarget
- Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
- (2014) M N Saha et al. BRITISH JOURNAL OF CANCER
- MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways
- (2014) Shi-Yun Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo
- (2014) Avinashnarayan Venkatanarayan et al. NATURE
- p53 protein aggregation promotes platinum resistance in ovarian cancer
- (2014) Y Yang-Hartwich et al. ONCOGENE
- The aggregation of mutant p53 produces prion-like properties in cancer
- (2014) Luciana P Rangel et al. Prion
- Prion-like aggregation of mutant p53 in cancer
- (2014) Jerson L. Silva et al. TRENDS IN BIOCHEMICAL SCIENCES
- microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network
- (2014) Y. Hoffman et al. Journal of Molecular Cell Biology
- Contribution of p53 to Metastasis
- (2014) E. Powell et al. Cancer Discovery
- The role of ubiquitin modification in the regulation of p53
- (2013) Andreas K. Hock et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
- (2013) Tomer Cooks et al. CANCER CELL
- A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells
- (2013) Alessia Garufi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Small molecule induced reactivation of mutant p53 in cancer cells
- (2013) Xiangrui Liu et al. NUCLEIC ACIDS RESEARCH
- Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma Cells
- (2013) Zheng Wang et al. PLoS One
- A closer look at prion strains
- (2013) Laura Solforosi et al. Prion
- Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53
- (2013) Christopher D. Wassman et al. Nature Communications
- Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis
- (2012) Claudia Fiorini et al. APOPTOSIS
- Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity
- (2012) Cristian A. Lasagna-Reeves et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils
- (2012) Ana P. D. Ano Bom et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
- (2012) P Dong et al. ONCOGENE
- Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
- (2012) Milena Wiech et al. PLoS One
- p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
- (2012) Abhinav K. Jain et al. PLOS BIOLOGY
- p53 and its mutants in tumor cell migration and invasion
- (2011) Patricia A. J. Muller et al. JOURNAL OF CELL BIOLOGY
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
- (2011) Taewan Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
- (2011) Chun-Ju Chang et al. NATURE CELL BIOLOGY
- Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
- (2011) Jie Xu et al. Nature Chemical Biology
- p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
- (2011) N. H. Kim et al. Science Signaling
- Tumor suppressor p53 meets microRNAs
- (2011) Z. Feng et al. Journal of Molecular Cell Biology
- Role of p53 in Cell Death and Human Cancers
- (2011) Toshinori Ozaki et al. Cancers
- Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells
- (2010) Fei Wang et al. APOPTOSIS
- The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
- (2010) M. Grusch et al. CURRENT CANCER DRUG TARGETS
- Prion-like transmission of protein aggregates in neurodegenerative diseases
- (2010) Patrik Brundin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Energy metabolism in adult neural stem cell fate
- (2010) Victoria A. Rafalski et al. PROGRESS IN NEUROBIOLOGY
- p53 post-translational modification: deregulated in tumorigenesis
- (2010) Chao Dai et al. TRENDS IN MOLECULAR MEDICINE
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- An MDM2 antagonist (MI-319) restores p53 functions and increases the life span of orally treated follicular lymphoma bearing animals
- (2009) Ramzi M Mohammad et al. Molecular Cancer
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells
- (2009) K.-H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NF- B Family of Transcription Factors and Its Regulation
- (2009) A. Oeckinghaus et al. Cold Spring Harbor Perspectives in Biology
- Suppression of Familial Adenomatous Polyposis by CP-31398, a TP53 Modulator, in APCmin/+ Mice
- (2008) C. V. Rao et al. CANCER RESEARCH
- Mutant p53 targeting by the low molecular weight compound STIMA-1
- (2008) Nicole Zache et al. Molecular Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started